Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guidant (GDT) -- Ignore unavailable to you. Want to Upgrade?

To: Lighthouse who wrote (190)	11/22/2001 8:53:36 AM
From: D.Austin	Read Replies (1) \| Respond to of 235

Did bullish Bear Stearns really miss out on the 80+ % move from July ??? 11:41AM Bear Stearns bullish on STJ (STJ) by Michael Baron St. Jude Medical (STJ) is rising $5.68, or 8.2 percent, to $74.78, after Bear Stearns raised its rating on the company's stock to "buy" from "attractive" due to recent positive results of a multi-center automatic defibrillator implantation trial reported by Guidant (GDT), which the firm also upgraded. The trial (see 10:04 am ET item) showed that the implanted defibrillators reduced mortality by 30 percent compared to the control group. These positive results led to the trial's early termination. . . .Happy Thanksgiving and God Bless the USA